Skip to content

Flow-by-flow quantitative measurement of aerosol dispersion associated with the use of high-flow nasal oxygen therapy in healthy adults.

Flow-by-flow quantitative measurement of aerosol dispersion associated with the use of high-flow nasal oxygen therapy in healthy adults.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1032220007
Enrollment
25
Registered
2022-04-08
Start date
2022-04-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Okuda Yasuhisa
Lead Sponsor
Ugajin Wakana
Collaborator
Saitou Tomoyuki
Collaborator
Asai Takashi
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who requested to participate through the volunteer recruitment process Those who have given written consent to participate in this study Persons 20 years of age or older

Exclusion criteria

Exclusion criteria: Persons with cold symptoms Persons with signs of infection Persons with respiratory disease Persons of body temperature of 38 degrees Celsius or higher Patients with novel coronavirus and their close contacts

Design outcomes

Primary

MeasureTime frame
Aerosol dispersal when wearing a high-flow nasal oxygen cannula

Contacts

Public ContactWakana Ugajin

Dokkyo Medical University Saitama Medical Center, Department of Anesthesia

wakau.t.kuro@gmail.com+81-489-65-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026